Drug Profile

Rabies single dose vaccine - CPL Biologicals

Alternative Names: Rabies single dose vaccine-CPL Biologicals

Latest Information Update: 02 Sep 2024

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Novavax
Developer CPL Biologicals
Class Viral vaccines
Mechanism of Action Immunostimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Preclinical Viral infections

Most Recent Events

02 Sep 2024 Rabies single dose vaccine is still in preclinical development for Viral infections in India (unspecified route) (CPL Biologicals pipeline, September 2024)
28 Feb 2024 No recent reports of development identified for preclinical development in Viral-infections in India
02 Jan 2020 Preclinical trials in Viral infections in India (unspecified route) (CPL Biologicals pipeline, January 2020)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com